The Clorox Company (NYSE:CLX) Shares Bought by Benjamin F. Edwards & Company Inc.

Benjamin F. Edwards & Company Inc. raised its position in shares of The Clorox Company (NYSE:CLX) by 15.8% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 55,775 shares of the company’s stock after buying an additional 7,602 shares during the period. Benjamin F. Edwards & Company Inc.’s holdings in Clorox were worth $7,611,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also modified their holdings of CLX. GoalVest Advisory LLC acquired a new position in Clorox during the 1st quarter worth about $31,000. First Foundation Advisors acquired a new position in shares of Clorox in the first quarter valued at approximately $31,000. Core Wealth Advisors Inc. purchased a new stake in Clorox during the 4th quarter worth approximately $29,000. Innealta Capital LLC purchased a new stake in Clorox during the 2nd quarter worth approximately $30,000. Finally, Trifecta Capital Advisors LLC lifted its holdings in Clorox by 139.8% during the 2nd quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock worth $30,000 after buying an additional 130 shares in the last quarter. 78.53% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Clorox

In related news, EVP Angela C. Hilt sold 1,733 shares of the company’s stock in a transaction on Friday, September 6th. The shares were sold at an average price of $165.52, for a total value of $286,846.16. Following the completion of the sale, the executive vice president now owns 13,471 shares in the company, valued at approximately $2,229,719.92. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 0.51% of the stock is owned by company insiders.

Clorox Trading Up 0.8 %

Shares of Clorox stock opened at $163.33 on Friday. The company has a current ratio of 1.03, a quick ratio of 0.63 and a debt-to-equity ratio of 5.04. The company has a fifty day simple moving average of $149.14 and a 200-day simple moving average of $143.78. The stock has a market cap of $20.28 billion, a price-to-earnings ratio of 84.63, a PEG ratio of 3.29 and a beta of 0.40. The Clorox Company has a 12-month low of $114.68 and a 12-month high of $169.09.

Clorox (NYSE:CLX) last released its quarterly earnings data on Thursday, August 1st. The company reported $1.82 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.54 by $0.28. Clorox had a net margin of 3.95% and a return on equity of 281.12%. The company had revenue of $1.90 billion during the quarter, compared to the consensus estimate of $1.97 billion. On average, equities analysts forecast that The Clorox Company will post 6.63 EPS for the current fiscal year.

Clorox Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, November 7th. Shareholders of record on Wednesday, October 23rd will be given a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a yield of 2.99%. The ex-dividend date of this dividend is Wednesday, October 23rd. Clorox’s dividend payout ratio (DPR) is 252.85%.

Analyst Ratings Changes

Several equities analysts have commented on the stock. Deutsche Bank Aktiengesellschaft boosted their price target on shares of Clorox from $144.00 to $151.00 and gave the stock a “hold” rating in a research note on Friday, August 2nd. JPMorgan Chase & Co. lowered their target price on Clorox from $150.00 to $148.00 and set a “neutral” rating for the company in a research note on Friday, August 2nd. Citigroup increased their price target on Clorox from $165.00 to $170.00 and gave the company a “neutral” rating in a research report on Friday, September 6th. Argus raised Clorox to a “hold” rating in a research report on Tuesday, June 4th. Finally, TD Cowen started coverage on shares of Clorox in a report on Tuesday, July 23rd. They issued a “sell” rating and a $122.00 target price on the stock. Six research analysts have rated the stock with a sell rating and thirteen have given a hold rating to the company. According to data from MarketBeat.com, Clorox has a consensus rating of “Hold” and an average price target of $143.50.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.